Physician

Charles F. Gebhardt, M.D.

According to 2025 Medicare claims, Charles Gebhardt, M.D. (NPI: 1407842859) practices internal medicine in the Albany, GA market, with the plurality of this provider's patient population coming from Dougherty, GA. This provider's primary affiliated billing organization is MEDICAL ASSOCIATES OF ALBANY, P.C. (NPI: 1952396665; TIN: 582252315) and primary practice location at 31763-7228. Gebhardt is affiliated with the Aledade 34 GA MSSP Enhanced (ACO ID: A4737), participating under the MSSP model.

Gebhardt's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 314 traditional Medicare patients, billed 7,323 HCPCS/CPT codes, and received $168,332 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 13,573 prescription claims across 946 beneficiaries totaling $1,511,411 in drug costs, led by Mounjaro (Tirzepatide). DME data shows 272 claims. Open Payments data shows 134 records totaling $2,217. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $828,501 to $1,511,411. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $33,297 and ending at $13,738.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	565	9,384	$234,152
2016	573	10,017	$238,783
2017	587	9,903	$238,122
2018	601	9,503	$222,154
2019	524	8,651	$216,834
2020	437	7,234	$177,390
2021	403	6,930	$199,241
2022	357	7,150	$196,632
2023	330	6,593	$178,323
2024	314	7,323	$168,332

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	564	15,170	$828,501
2016	665	16,530	$939,219
2017	709	16,068	$994,696
2018	748	15,230	$1,091,485
2019	749	13,407	$1,004,564
2020	688	12,329	$1,023,079
2021	720	11,740	$971,456
2022	772	11,297	$1,067,493
2023	905	11,731	$1,278,434
2024	946	13,573	$1,511,411

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	169	536	$16,056
2016	232	838	$20,615
2017	119	485	$9,069
2018	128	492	$8,320
2019	155	460	$10,011
2020	120	528	$12,786
2021	106	369	$13,539
2022	54	316	$13,036
2023	48	324	$15,186
2024	11	272	$11,470

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	297	791	$77
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	264	649	$11
80053	Blood test, comprehensive group of blood chemicals	281	629	$10
83721	Ldl cholesterol level	282	601	$10
36415	Insertion of needle into vein for collection of blood sample	286	675	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Mounjaro	Tirzepatide	140	5,192	$186,996
Rybelsus	Semaglutide	112	5,520	$175,890
Ozempic	Semaglutide	114	3,920	$128,092
Eliquis	Apixaban	137	6,080	$116,753
Jardiance	Empagliflozin	95	5,672	$108,500

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	12	$2,512
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	24	$1,708
A7033	Pillow for use on nasal cannula type interface, replacement only, pair	N	N/R	18	$1,529
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	N/R	21	$1,037
A7031	Face mask interface, replacement for full face mask, each	N	N/R	11	$1,035

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	134	$2,217	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Charles F. Gebhardt, M.D.?

Tedicare shows public-source Medicare data for Charles F. Gebhardt, M.D. (NPI 1407842859), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Charles F. Gebhardt, M.D. have ACO affiliation data?

Charles F. Gebhardt, M.D. is shown with ACO affiliation data for Aledade 34 GA MSSP Enhanced (MSSP, ACO ID A4737).

What billing organization is linked to Charles F. Gebhardt, M.D.?

Charles F. Gebhardt, M.D. is linked to MEDICAL ASSOCIATES OF ALBANY, P.C. (billing NPI 1952396665) in the available physician profile data.

Does Charles F. Gebhardt, M.D. have Open Payments data?

Charles F. Gebhardt, M.D. has 134 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.